Back to jobs
New

Associate Director, QA Oversight for QC

Burlington, MA

Working with Us

MBX Biosciences is a clinical-stage biopharmaceutical company headquartered in Carmel, Indiana, with a secondary office in Burlington, MA.  Our mission is to transform the lives of people impacted by endocrine and metabolic disorders through our novel precision peptides.

Leveraging our proprietary Precision Endocrine Peptides (PEPs)™ platform, we are pioneering technology designed to overcome key limitations of existing therapies and enhance efficacy, tolerability, safety and convenience. Our team is advancing a pipeline of novel candidates with clinically validated targets, established endpoints for regulatory approval, and strong market potential.

Our pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism, currently preparing for Phase 3 development, and a growing obesity portfolio that includes MBX 4291 in Phase 1 development, MBX 5765, a next-generation amycretin prodrug designed for once-monthly-dosing, as well as MBX 6180, a GLP/GIP/GCGR triple agonist prodrug for once monthly dosing; all of which optimize our PEP platform.

If you’re passionate about advancing innovative treatments for patients and shaping the future of precision peptide therapeutics, this is your chance to make a real impact alongside a fast-paced, growing, mission-driven team.  To learn more, visit our website mbxbio.com and follow us on LinkedIn.

What You’ll Do

The Associate Director of QA Oversight for QC and CTO provides strategic leadership and independent compliance oversight for all internal Quality Control (QC) operations and external Contract Testing Organizations (CTOs). This role ensures that all product testing, stability programs, and environmental monitoring workflows—whether executed in-house or by third-party vendors—strictly adhere to cGMP, data integrity regulations, and global health authority expectations. The Associate Director manages vendor quality agreements, drives external investigation closures, and acts as the ultimate authority on the compliance of data used for product release. 

Key Responsibilities Include:

  • External Lab (CTO) Governance: Establish, maintain, and execute the QA oversight strategy for all approved Contract Testing Organizations (CTOs). Serve as the primary QA point of contact for external testing escalations.
  • Vendor Audits & Qualification: Lead or oversee routine qualification and for-cause compliance audits of CTO facilities. Ensure external labs maintain robust systems for data backup, instrument calibration, and analyst training.
  • Quality Agreements: Negotiate, author, and maintain Quality Agreements with CTOs to ensure clear alignment on roles, testing timelines, data transfer protocols, and regulatory expectations.
  • External Deviation & OOS Management: Provide QA oversight and approval for Out-of-Specification (OOS) results, Out-of-Trend (OOT) data, and laboratory deviations originating at CTO sites. Ensure external root cause investigations are scientifically rigorous.
  • Data Integrity Governance: Serve as the authority for data integrity (ALCOA+ principles) across both internal QC systems and external CTO workflows. Verify that third-party labs utilize compliant audit trails and electronic data lifecycle management
  • Tech Transfer & Validation Review: Provide high-level QA sign-off on analytical method transfer protocols, co-validations, and method verification studies between internal sites and external CTOs.
  • Inspection Readiness & Leadership: Lead regulatory inspection preparation for the internal QC footprint and support CTO sites during health authority audits that involve the company's products. 

What You Bring

  • Bachelor’s or Master’s degree in chemistry, Microbiology, pharmacy, or a related scientific discipline
  • 8+ years of experience in the pharma/biotech industry, including a strong blend of internal QA/QC experience and direct external vendor management (CMO/CTO oversight).
  • Regulatory & Vendor Management Knowledge
  • Deep knowledge of global cGMP regulations (21 CFR Parts 210/211/11, EU Annex 11) and standard practices for outsourcing pharmaceutical testing
  • Strong technical understanding of advanced analytical methodologies (HPLC/GC, mass spectrometry, cell culture assay) and electronic laboratory systems (LIMS, Empower)
  • Proven track record of managing external partnerships, cross-functional collaboration, and the ability to influence compliance cultures at third-party organizations.

Travel & In Office Presence 

You will be expected to travel periodically based on the needs of the business, including attendance at Together Weeks, Together Days, and functional meetings as requested by the team. Employees are expected to work on hybrid schedules, consistent with local office practices and the terms of the companies in office policy as in effect from time to time.

EEO Statement:  

MBX Biosciences is an Equal Opportunity Employer and is committed to treating all applicants fairly without discrimination. We welcome applications from all individuals, regardless of race, national origin, gender, age, physical characteristics, social origin, disability, union membership, religion, family status, pregnancy, sexual orientation, gender identity, gender expression or any unlawful criterion under applicable law.  

Create a Job Alert

Interested in building your career at MBX Biosciences? Get future opportunities sent straight to your email.

Apply for this job

*

indicates a required field

Phone
Resume/CV*

Accepted file types: pdf, doc, docx, txt, rtf

Cover Letter

Accepted file types: pdf, doc, docx, txt, rtf


Select...
Select...

U.S. Standard Demographic Questions

We invite applicants to share their demographic background. If you choose to complete this survey, your responses may be used to identify areas of improvement in our hiring process.
Select...
Select...
Select...
Select...
Select...
Select...

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in MBX Biosciences’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Select...
Select...
Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...